Here is your latest research news for March, 2022. Stay up to date on monthly research updates with us! Sanguine is currently recruiting for 51 research studies. Check out the latest Sanguine studies here.
At-Home COVID-19 Tests: Americans can now order additional COVID-19 at-home tests that are FDA approved. This is a second round of free tests provided by the government.
COVID-19 Brain Changes: According to a new study, COVID-19 may result in a loss of gray matter and tissue damage in the brain. The study involved 785 participants between the ages of 51 and 80 years old and found shrinkage in brain tissue especially in areas of the brain related to sense of smell.
New Research Technology: Researchers at the University of Surrey and King’s College London have developed a process of growing pig tissue in the lab to model heart attacks. The process means potentially better health outcomes with less reliance on live animal models.
Sickle Cell Disease Research News Updates
SCD Gene-Editing Cure: Read about Jimi Olaghere who recently participated in a sickle cell clinical trial and was cured from sickle cell disease through a revolutionary gene-editing treatment. The procedure has been performed on 45 patients so far and data is still being collected.
New SCD Treatment: According to a press release during this past March of 2022, Nicox’s partner, Fera Pharmaceuticals, has obtained orphan designation for Naproxcinod for the treatment of sickle cell disease. Orphan designation is provided for drugs or biologics that are involved in the treatment, diagnosis, or prevention of rare diseases.
Lupus Research News Updates
Lupus and Stem Cells: A new study shows that stem cells may help in the treatment of lupus. Early clinical trials show that the stem cell therapy may be effective in treating refractory lupus. Mice studies have shown efficacy of stem cell therapy in treatment of lupus nephritis.
Lupus Monitoring: Currently, clinical testing for lupus involves multiple blood draws. A new study suggests that noninvasive urine and saliva samples may be successfully utilized to monitor disease activity.
By: Neelem Sheikh